Market Cap

PT Indofarma Market Capitalization:

Rp390.51 Billion

IDR as of July 1, 2024

US$23.8 Million

business PT Indofarma Company Profile

PT Indofarma Main Stock Listing

IDX: INAF

Market Capitalization History of PT Indofarma

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of PT Indofarma market cap

Date Market Cap YoY Change
Jan. 1, 2024 Rp1.339 T -48.26%
Jan. 1, 2023 Rp2.588 T -59.47%
Jan. 1, 2022 Rp6.384 T -31.33%
Jan. 1, 2021 Rp9.298 T 257.14%
Jan. 1, 2020 Rp2.603 T -83.17%
Jan. 1, 2019 Rp15.465 T -9.27%
Jan. 1, 2018 Rp17.046 T 135.04%
Jan. 1, 2017 Rp7.252 T 824.90%
Jan. 1, 2016 Rp784.12 B -11.85%
Jan. 1, 2015 Rp889.49 B 75.00%
Jan. 1, 2014 Rp508.28 B -53.14%
Jan. 1, 2013 Rp1.085 T

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

PT Indofarma Categories

Indonesia languages Healthcare languages Drug Manufacturers—Specialty & Generic
Indonesia Healthcare Indonesia Drug Manufacturers—Specialty & Generic

Stocks & Indices

PT Indofarma has the following listings and related stock indices.


Stock: IDX: INAF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.